Clinical Trial Update: The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of SGLT2 inhibitors in patients with acute kidney injury, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Kidney Injury | Phase 2 | Status: RECRUITING